See analyst estimates and all valuation multiples for Health & Beauty
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $442B | 7.3x | 16.9x | |
| $363B | 4.2x | 15.3x | |
| $243B | 4.7x | 19.8x | |
| $166B | 2.5x | 11.3x | |
| $85.2B | 1.6x | 7.7x | |
| $75.3B | 3.7x | 15.3x | |
| $66.1B | 3.5x | 12.6x | |
| $60.2B | 8.4x | 36.6x | |
| $53.8B | 3.6x | 14.5x | |
| $48.8B | 9.5x | 41.4x | |
| $48.7B | 3.3x | 22.8x | |
| $42.1B | 4.5x | 18.6x | |
| $40.9B | 2.7x | 12.3x | |
| $34.5B | 1.4x | 7.9x | |
| $31.8B | 2.6x | 17.4x | |
| $23.7B | 3.8x | 16.8x | |
| $23.2B | 1.5x | 8.3x | |
| $22.5B | 2.0x | 11.3x | |
| $22.3B | 2.2x | 6.2x | |
| $17.4B | 1.6x | 10.8x | |
| $14.1B | 8.4x | 40.7x | |
| $12.6B | 2.1x | 14.2x | |
| $11.9B | 2.1x | 10.1x | |
| $10.7B | 7.6x | 42.5x | |
| $10.4B | 6.8x | 27.1x | |
| $9.7B | 6.7x | 35.8x | |
| $8.2B | 1.3x | 13.0x | |
| $8.0B | 1.3x | 7.6x | |
| $6.8B | 1.2x | 6.6x | |
| $6.2B | 9.2x | 28.8x | |
| $6.1B | 4.0x | 20.1x | |
| $6.0B | 6.1x | 23.8x | |
| $5.3B | 1.2x | 7.2x | |
| $5.3B | 2.5x | 14.1x | |
| $4.7B | 1.6x | 10.8x | |
| $4.3B | 8.9x | 34.5x | |
| $4.3B | 1.5x | 6.5x | |
| $4.2B | 9.8x | 29.9x | |
| $4.1B | 3.6x | 11.0x | |
| $4.0B | 1.2x | 6.9x | |
| $3.9B | 1.2x | 7.7x | |
| $3.7B | 3.0x | 18.8x | |
| $3.5B | 4.1x | 10.2x | |
| $3.5B | 1.7x | 10.2x | |
| $3.5B | 2.1x | 11.8x | |
| $2.9B | 2.0x | 9.8x | |
| $2.9B | 0.8x | 5.3x | |
| $2.9B | 1.3x | 9.6x | |
| $2.8B | 8.5x | 31.8x | |
| $2.8B | 0.6x | 5.4x | |
| $2.6B | 2.5x | 11.1x | |
| $2.6B | 1.0x | 7.7x | |
| $2.6B | 1.1x | 5.5x | |
| $2.3B | 5.5x | 20.6x | |
| $2.3B | 6.0x | 17.3x | |
| $2.2B | 0.5x | 6.4x | |
| $2.2B | 3.8x | 18.8x | |
| $2.1B | 2.7x | 19.1x | |
| $2.1B | 0.9x | 6.8x | |
| $2.0B | 1.8x | 13.0x | |
| $2.0B | 2.5x | 12.3x | |
| $1.9B | 1.1x | 9.8x | |
| $1.8B | 2.7x | 12.8x | |
| $1.6B | 6.2x | 17.6x | |
| $1.6B | 0.9x | 7.0x | |
| $1.6B | 2.2x | 11.0x | |
| $1.6B | n/a | n/a | |
| $1.5B | 1.2x | 8.5x | |
| $1.5B | 0.7x | 8.0x | |
| $1.4B | 0.8x | 6.4x | |
| $1.4B | 1.8x | 7.4x | |
| $1.3B | 0.6x | 6.0x | |
| $1.2B | 2.7x | 12.6x | |
| $1.0B | 1.5x | 9.9x | |
| $981M | 4.0x | 56.9x | |
| $979M | 0.9x | 8.2x | |
| $967M | 7.6x | 28.7x | |
| $893M | 1.1x | 6.0x | |
| $870M | 1.9x | 9.2x | |
| $738M | n/a | n/a | |
| $661M | n/a | n/a | |
| $601M | 0.4x | n/a | |
| $566M | 0.8x | 6.4x | |
| $560M | 3.3x | 13.1x | |
| $546M | 0.2x | 1.3x | |
| $544M | 1.3x | 7.7x | |
| $538M | 0.8x | 3.7x | |
| $520M | n/a | n/a | |
| $448M | 1.5x | -21.2x | |
| $420M | 2.1x | -45.8x | |
| $394M | n/a | n/a | |
| $387M | 1.4x | 17.6x | |
| $351M | 1.2x | 9.4x | |
| $349M | n/a | n/a | |
| $340M | 0.8x | 9.7x | |
| $297M | n/a | n/a | |
| $254M | 5.0x | 19.0x | |
| $223M | n/a | n/a | |
| $222M | 0.6x | 10.1x | |
| $208M | 0.4x | 12.3x | |
| $208M | n/a | n/a | |
| $197M | 1.0x | 9.7x | |
| $192M | 2.3x | 13.6x | |
| $191M | 1.3x | 5.9x | |
| $170M | 0.8x | 3.7x | |
| $164M | 0.7x | 6.6x | |
| $159M | 0.8x | 5.8x | |
| $140M | 2.2x | 8.1x | |
| $133M | n/a | n/a | |
| $129M | 0.5x | 6.0x | |
| $85.1M | n/a | n/a | |
| $60.4M | 0.3x | 6.4x | |
| $59.9M | 2.3x | 9.7x | |
| $48.0M | 1.1x | n/a | |
| $42.4M | n/a | n/a | |
| $42.2M | n/a | n/a | |
| $39.8M | n/a | n/a | |
| $29.0M | n/a | n/a | |
| $28.1M | 2.3x | n/a | |
| $26.1M | n/a | n/a | |
| $25.7M | 1.4x | -15.3x | |
| $25.6M | n/a | n/a | |
| $18.8M | n/a | n/a | |
| $12.1M | n/a | n/a | |
| $8.5M | n/a | n/a | |
| $6.7M | n/a | n/a | |
| $5.4M | n/a | n/a | |
| $1.3M | n/a | n/a | |
| -$31.3M | -0.1x | -52.2x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Health & Beauty